Jim Butler is receiving his monthly 45-minute infusion of drugs.
What kind of drugs? He doesn’t know. Nor do the nurses administering them. Could be an experimental medicine that will help his brain fight Alzheimer’s disease. Or could be a placebo that does nothing.
Only one doctor conducting the medical research at Great Lakes Clinical Trials knows what drug Butler is getting, and even he doesn’t know what the effect will be.
None of this influences Butler’s determination to be here.
“I got an Alzheimer’s diagnosis four years ago,” said Butler, 71, who describes the disease as causing “multiple times a day, cognitive hiccups, confusion.”
One thing he is not confused about is the importance of participating in research.
“The simplest reason is I like to be very proactive about my diagnosis,” he said. “My game plan is not to get overwhelmed and unsettled at these things. To try to smile at them, dismiss them, let them go. A clinical trial is an enormously great way to do that.”
Clinical trials are the minor leagues of medicine. Before drug companies can sign up a star cure to wow the public, they need to know if it can deliver. To do that, they spend billions of dollars and commission hundreds of small clinics like Great Lakes Clinical Trials, which opened in Andersonville in 2014. There is a second location in Arlington Heights.
To continue reading, click here.